Back to Search
NANCY RICHERT, MD, PHD
MD, PHD
Neuroradiology Physician
NPI: 1437341435Individual
Specialties, Licenses & Credentials
Neuroradiology PhysicianPrimary
Radiology — Neuroradiology
Code: 2085N0700X
D0048312(MD)
Pediatric Radiology Physician
Radiology — Pediatric Radiology
Code: 2085P0229X
D0048312(MD)
Research & Publications (20)
Relationship between inflammatory lesions and cerebral atrophy in multiple sclerosis.
PMID 16505310·Neurology·2006
8-other
Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis.
PMID 11321194·Mult Scler·2001
8-other
MRI and clinical activity in MS patients after terminating treatment with interferon beta-1b.
PMID 10773853·Mult Scler·2000
3-trial
Tissue-specific imaging is a robust methodology to differentiate in vivo T1 black holes with advanced multiple sclerosis-induced damage.
PMID 19406765·AJNR Am J Neuroradiol·2009
8-other
Thalamic involvement and its impact on clinical disability in patients with multiple sclerosis: a diffusion tensor imaging study at 3T.
PMID 19369608·AJNR Am J Neuroradiol·2009
8-other
Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis.
PMID 19364933·Arch Neurol·2009
3-trial
Regulatory T cells are reduced during anti-CD25 antibody treatment of multiple sclerosis.
PMID 19364932·Arch Neurol·2009
3-trial
Visualizing the cause of gray matter atrophy in multiple sclerosis.
PMID 19204151·Arch Neurol·2009
8-other
Heterogeneity in response to interferon beta in patients with multiple sclerosis: a 3-year monthly imaging study.
PMID 19001157·Arch Neurol·2009
3-trial
The effect of interferon beta-1b on size of short-lived enhancing lesions in patients with multiple sclerosis.
PMID 18990070·Expert Opin Biol Ther·2008
8-other
Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosis.
PMID 18541787·Arch Neurol·2008
3-trial
A case study on the effect of neutralizing antibodies to interferon beta 1b in multiple sclerosis patients followed for 3 years with monthly imaging.
PMID 17666095·Clin Exp Immunol·2007
8-other
Interferon-beta-1b effects on re-enhancing lesions in patients with multiple sclerosis.
PMID 16320725·Mult Scler·2005
3-trial
MRI as a marker for disease heterogeneity in multiple sclerosis.
PMID 16217061·Neurology·2005
4-observational
Effects of interferon beta-1b on black holes in multiple sclerosis over a 6-year period with monthly evaluations.
PMID 16157739·Arch Neurol·2005
3-trial
Contrast-enhanced MRI lesions during treatment with interferonbeta-1b predict increase in T1 black hole volume in patients with relapsing-remitting multiple sclerosis.
PMID 15794386·Mult Scler·2005
3-trial
Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta.
PMID 15161974·Proc Natl Acad Sci U S A·2004
3-trial
Interferon-beta-1b slows progression of atrophy in RRMS: Three-year follow-up in NAb- and NAb+ patients.
PMID 15007120·Neurology·2004
3-trial
Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years.
PMID 12821527·Brain·2003
8-other
Estimating cerebral atrophy in multiple sclerosis patients from various MR pulse sequences.
PMID 12356210·Mult Scler·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- NATIONAL INSTITUTE OF NEUROLOGIC DISORDERS AND STROKE, BLDG 10, RM B1N256 NIH
BETHESDA, MD 20892 - Phone
- (301) 435-4488
Quick Facts
- NPI
- 1437341435
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile